Metabolites are small molecules that are chemically transformed during metabolism and, as such, they provide a functional readout of cellular state. Unlike genes and proteins, the functions of which are subject to epigenetic regulation and posttranslational modifications, respectively, metabolites serve as direct signatures of biochemical activity and are therefore easier to correlate with phenotype. In this context, metabolite profiling, or metabolomics, has become a powerful approach that has been widely adopted for clinical diagnostics.
Metabolites are small molecules that are chemically transformed during metabolism and, as such, they provide a functional readout of cellular state. Unlike genes and proteins, the functions of which are subject to epigenetic regulation and posttranslational modifications, respectively, metabolites serve as direct signatures of biochemical activity and are therefore easier to correlate with phenotype. In this context, metabolite profiling, or metabolomics, has become a powerful approach that has been widely adopted for clinical diagnostics.
The metabolome -typically defined as the collection of small molecules produced by cells -offers a window for interrogatin g how mechanistic biochemistry relates to cellular phenotype. With developments in mass spectrometry, it is now possible to rapidly measure thousands of metabolites simultaneously from only minimal amounts of sample 1 . In particular, recent innovations in instrumentation, bioinformatic tools and software enable the comprehensive analysi s of cellular metabolites without bias. In many instances, these metabolites can be spatially localized within biological specimen s with imaging mass spectrometry 2, 3 . The application of these technologies has revealed system-wide alterations of unexpected metabolic pathways related to phenotypic perturbations. Moreover, many of the molecules detected are currently not included in databases and metabolite repositories, indicating the extent to which our picture of cellular metabolism is incomplete 4, 5 . Nonetheless, the field of metabolomics has made remarkable progress within the past decade and has implemented new tools that have offered mechanistic insights by allowing for the correlation of biochemical changes with phenotype.
In this Innovation article, we first define and differentiate between the targeted and untargeted approaches to metabolomics. We then highlight the value of untargeted metabolomics in particular and outlin e a guide to performing such studies. Finally, we describe selected applications of un targeted metabolomics and discuss their potential in cell biology.
Designing a metabolomic experiment
The first step in performing metabolomics is to determine the number of metabolites to be measured. In some instances, it may be of interest to examine a defined set of metabolites by using a targeted approach.
In other cases, an untargeted or global approach may be taken in which as many metabolites as possible are measured and compared between samples without bias. Ultimately, the number and chemical composition of metabolites to be studied is a defining attribute of any metabolomic experiment and shapes experimental design with respect to sample preparation and choice of instrumentation.
Targeted metabolomics. This approach refers to a method in which a specified list of metabolites is measured, typically focusing on one or more related pathways of interest 6 . Targeted metabolomic approaches are commonly driven by a specific biochemical question or hypothesis that motivates the investigation of a particular pathway (FIG. 1a) . This approach can be effective for pharmacokinetic studies of drug metabolism as well as for measuring the influence of therapeutics or genetic modifications on a specific enzyme 7 . Developments in mass spectro metry and nuclear magnetic resonanc e (NMR) offer distinct advantages for performing targeted metabolomic studies because of their specificity and quantitative reproducibility; however, there are many analytical tools available for measuring metabolites that could in principle be considered, such as ultraviolet-visible spectroscopy and flame ionization. Although the term 'metabolomics' was only recently coined, examples of targeted studies of metabolites date back to the earliest of scientific inquiries [8] [9] [10] [11] [12] . Therefore, there is a wealth of literature investigating optimal protocols for the sample preparation and analysis of specifi c classes of metabolites that has been discusse d extensively elsewhere [13] [14] [15] [16] [17] . Not to diminish their significance, targeted approaches have undoubtedly played an important part in the development of the field of metabolomics. In particular, advances have been made in using tripl e quadrupole (QqQ) mass spectrometry to perform selected reaction monitoring experiments such that routine methods are now available for analysing most of the metabolites in central carbon metabolism, as well as amino acids and nucleotides at [18] [19] [20] . These developments provide a highly sensitive and robust method for measuring a significant number of biologically important metabolites with relatively high throughput. Additionally, QqQ mass spectrometry methods are quantitatively reliable and therefore offer opportunities to achieve absolute quantification of low-concentration metabolites that are difficult to detect with less sensitive methods such as NMR (FIG. 1a) . By applying QqQ mass spectrometry-based methods to human plasma, targeted lists of metabolites can be screened as potential metabolic signatures for disease. For example, targeted screening recently revealed citric acid metabolites and a small group of essential amino acids as metabolic signatures of myocardial ischaemia and diabetes, respectively 21, 22 . In another diabetes-related study, targeted metabolomic methods were used to investigate patient response to glucose challenge 23 . Here, the levels of specific plasma metabolites were measured after glucose ingestion to determine insulin response in patients.
Untargeted metabolomics. Untargeted metabolomic methods are global in scope and have the aim of simultaneously measuring as many metabolites as possible from biological samples without bias (FIG. 1b) . Although untargeted metabolomics can be performed by using either NMR or mass spectrometry technologies, liquid chromatography followed by mass spectrometry (LC/MS) enables the detection of the most metabolites and has therefore been the technique of choice for global metabolite profiling efforts [24] [25] [26] [27] . By using LC/MS-based metabolomic methods, thousands of peaks can be routinely detected from biological samples 14, 28, 29 (FIG. 1b) . Each of these peaks is referred to as a metabolite feature and corresponds to a detected ion with a unique massto-charge ratio and a unique retention time (it should be noted that some metabolite s may produce more than one peak).
In contrast to targeted metabolomic results, untargeted metabolomic data sets are exceedingly complex, with file sizes on the order of gigabytes per sample for some new high-resolution mass spectrometry instruments. Manual inspection of the thousands of peaks detected is impractical and is complicated by experimental drifts in instrumentation. In LC/MS experiments, for example, there are deviations in retention time from sample to sample as a consequence of column degradation, sample carryover, small fluctuations in room temperature and mobile phase pH, as well as other variations. Although these challenges initially presented substantial obstacles for interpreting untargeted profiling data, major progress has been made in the past decade such that the ability to measure dysregulated peaks in global metabolomic data sets has now become routine with the introduction of metabolomic software such as MathDAMP, MetAlign, MZMine and XCMS 1, [30] [31] [32] [33] [34] . These accomplishments have already revealed that an astounding number first isolated from biological samples and subsequently analysed by liquid chromatography followed by mass spectrometry (LC/MS). After data acquisition, the results are processed by using bioinformatic software such as XCMS to perform nonlinear retention time alignment and identify peaks that are changing between the groups of samples measured. The m/z value s for the peaks of interest are searched in metabolite databases to obtain putative identifications. Putative identifications are then confirmed by comparing tandem mass spectrometry (MS/MS) data and retention time data to that of standard compounds. The untargeted workflow is global in scope and outputs data related to comprehensive cellular metabolism.
The untargeted [metabolomic] workflow is global in scope and outputs data related to comprehensive cellular metabolism. 
Shared metabolic difference
of metabolites remain uncharacterized with respect to their structure and function and, furthermore, that many of these uncharacterized metabolites change as a function of health and disease 4 . It is in this area that untargeted metabolomics has great potential to provide insights into fundamental biological processes. The remainder of this article will focus on the untargeted metabolomi c approach.
Impetus for untargeted metabolomics. In 1941, G. Beadle and E. L. Tatum proposed the one gene-one enzyme hypothesis 35 . This hypothesis was based on their experimental results showing that X-ray-induced mutant strains of the fungus Neurospora crassa were unable to carry out specific biochemical reactions 35, 36 . By systematically adding individual compounds to minimal N. crassa media and screening for those that rescue d the growth of mutant strains, Beadle and Tatum identified metabolites whose biosynthesis had been affected by genetic mutation. In doing so they were the first to directly connect genotype to phenotype at the molecular level. From their results they purported that a single gene serves as the primary control of a single function, in this case a specific biosynthetic reaction.
In many ways, modern day metabolomic experiments are similar in that they seek to connect genotype and phenotype by metabolite screening (FIG. 2a) . The experimental screening methods used today, however, are much advanced and allow us to study many more compounds simultaneously. Additionally, contemporary metabolic profiling experiments have the advantage of being complemented by genomic sequencing and proteomic screening [37] [38] [39] [40] . The field of systems biology has emerged from the combination of these global analyses and has shown us that the effects of a single, non-lethal gene mutation can be dauntingl y large 41 . Indeed, single gene mutations can affect a considerable number of metabolic pathways, thereby complicating the hypothesis that a single gene controls a single function (FIG. 2b) . Moreover, mutations in some unique genes have unexpected phenotypic effects. As an example, consider the abnormal dauer formation (daf-2) gene, which encodes an insulin-like recepto r in the nematode worm Caenorhabditis elegans. Mutations in daf-2 cause C. elegans to live more than twice as long as its wildtype counterpart and result in alterations in the abundance of at least 86 identified proteins 42, 43 . Or, as another example, consider genes that encode for enzymes of the phosphoinositide 3-kinase family. The protein products of these genes function in cell growth, proliferation, differentiation, motility and signal transduction, and mutations in these genes are thought to have an oncogenic role in some cancers 44 .
As these examples highlight, one gene can influence a multitude of metabolic pathways and thereby have a functional role in many cellular processes. Even knowledge of encoded protein structure is often insufficient to infer function at the wholeorganism level. Such functions can have intricate regulatory mechanisms involving epigenetic control, post-translational modifications and feedback loops that enable context-dependent activation or deactivation (FIG. 2a) . Thus, investigations aimed at detangling the role of any one specific gene benefit from systems-level analyses. These types of global studies were once limited to genes, transcripts and proteins, but technological developments over the past decade now allow for the untargeted profiling of metabolites and provide opportunities to comprehensively track metabolic reactions directly for the first time (FIG. 2b) .
Untargeted metabolomic workflow
Although untargeted metabolomic experiments are often hypothesis generating rather than hypothesis driven, it is important to carefully construct an experimental design that maximizes the number of metabolites detected and their quantitative reproducibility. With the workflow that is described below, metabolite identification is a manual and time-intensive process. Thus, the choice of sample type, preparation, chromatographic separation and analytical instrumentation should be considered and the choice that is most likely to yield highquality data used for analysis. Here, we focus on an LC/ MS-based workflow because this technique enables the detection of the highest number of metabolites and requires only Accordingly, it is easier to correlate metabolomic profiles with phenotype compared to genomic, transcriptomic and proteomic profiles. b | A schematic of a metabolic pathway. Metabolites are represented as circles, the levels of which can be measured by mass spectrometry. An alteration in a single enzyme can lead to a cascade of metabolic perturbations. Here, metabolites whose levels are altered in each of three theoretical genotypes are shown by coloured circles. Orange, light blue, and green circles represent metabolites altered in genotype 1, genotype 2 and genotype 3, respectively. Metabolites whose levels are similarly altered in multiple genotypes are represented by multi-coloured circles. These shared alterations may be useful in identifying phenotypically important biochemical perturbations. Sample preparation and data acquisition. The first step in the untargeted metabolomic workflow is to isolate metabolites from biological samples (FIG. 1b) . Several approaches involving sample homogenization and protein precipitation have been used, and these are described in detail elsewhere 14, 15, 45, 46 . Prior to mass spectrometry analysis, isolated metabolites are separated chromatographically by using relatively short solvent gradients (on the order of minutes) that allow for high-throughput analysis of large numbers of samples. The physiochemica l landscape of the metabolome is highly hetero geneous, so to increase the number of compounds detected, multiplexed methods for the extraction and separation of metabolites are used 47 . For example, extracting the same cells with both organic and aqueous solvents increases the number of hydrophobic and hydrophilic compounds observed, respectively. Similarly, reversedphase chromatography is better suited for the separation of hydrophobic metabolites, whereas hydrophili c-interactio n chromatography generally separates hydrophilic compounds more effectively. Most frequently, data is collecte d on a quadrupole time-of-flight (QTOF) mass spectrometer or an Orbitrap mass spectrometer, but other time-offlight and ion trap instruments can also be used 28, 29, 48 . Given the challenge of predicting tandem mass spectrometry (MS/ MS) fragmentation patterns for most metabolites, untargeted meta bolomic profiling data are typically acquired in MS 1 mode (that is, only the mass-to-charge ratio (m/z) of the intact metabolite is measured) 49, 50 , unlike the alternating MS 1 and MS/MS mode used in shotgu n omic approaches.
Data analysis.
With recent developments in bioinformatic tools, identification of metabolite peaks that are differentially altered between sample groups has become a relatively automated process. Several metabolomic software programs that provide a method for peak picking, nonlinear retention time alignment, visualization, relative quantification and statistical analysis are available 1,51 . The most widely used metabolomic software is XCMS, which is freely available online and allows users to upload data, perform data processing and browse results within a web-based interface 1 .
Metabolite identification.
It is important to note that the metabolomic software currently available does not output metabolite identifications. Rather, it provides a table of features with p-values and fold changes related to their difference in relative intensity between samples. To determine the identity of a feature of interest, the accurate mass of the compound is first searched in metabolite databases such as the Human Metabolome Database and METLIN [52] [53] [54] . A database match represents only a putative metabolite assignment that must be confirmed by comparing the retention time and MS/MS data of a model compound to that from the feature of interest in the research sample (FIG. 3) . Currently, MS/MS data for features selected from the profiling results are obtained from additional experiments, and matching of MS/MS fragmentation patterns is performed manually by inspection. These additional analyses are time intensive and represent the ratelimitin g step of the untargeted metabolomic workflow. Additionally, although metabolite databases have grown considerably over the past decade, a substantial number of metabolite features detected from biological samples do not return any matches. Identification of these unknown features requires de novo characterization with traditional methods. Taken together, it should be recognized that comprehensive identification of all metabolite features detected by LC/MS is currently impractical for most samples analysed.
Addressing the challenges
Untargeted metabolomics has revealed that the number of endogenous metabolites in biological systems is larger than anticipated and cannot be accounted for merely by canonical biochemical pathways. That is, the masses of a significant fraction of compounds detected in global analyses do not match any of the masses included in metabolite databases. Therefore, given that the metabolome is not encoded in the genome in the same way as proteins and transcripts, systems-level studies of metabolites are complicated by attempting to analyse an undefined set of molecules. In response to this challenge, metabolite 52, 53 . In addition to having molecular weights and experimental NMR spectra, the MetaboCards list information on each compound's biochemical pathway, concentration, anatomical location, metabolizing enzymes and related disorders when available. Currently, the Human Metabolome Database and METLIN are among the most widely used metabolite databases publicly available 54 . Like the Human Metabolome Database, METLIN contains experimental data for a subset of the total number of compounds included (~45,000), having MS/MS data available for more than 10,000 metabolites. For each of these metabolites, MS/MS data were experimentally generated from model compounds analysed at four different collision energies in both positive and negative mode. When used together with other publicly available tools, the Human Metabolome and METLIN databases can facilitate both metabolite identificatio n and data interpretation.
Meta-analysis: prioritizing unknowns.
Alterations in a single enzyme can lead to a cascade of metabolic perturbations that are functionally unrelated to the phenotype of interest. Untargeted metabolomic profiling of a particular disease or mutant can therefore reveal hundreds of alterations that are unlikely to have mechanistic implications. Given the resources needed to identify both known and unknown compounds, strategies to reduce lists of potentially interesting features before committing to identifying them are of great utility. One such strateg y is meta-analysis, in which untargeted profiling data from multiple studies are compared (FIG. 2b) . By comparing multiple models of a disease, for example, features that are not similarly altered in each of the comparisons may be de-prioritized as being less likely to be related to the shared pheno typic pathology. To automate the comparison of untargeted metabolomic data, freely available software called metaXCM S has been recently developed 55 . As proof of concept, metaXCMS was applied to investigate three pain models of different pathogenic aetiologie s: inflammation, acute heat and spontaneous arthritis 56 . Although hundreds of metabolite features were found to be altered in each model, only three were similarly dysregulated among all the groups. One of the shared metabolites was identified as histamine, a well-characterize d mediator of pain that works by several mechanisms. The application of similar data-reduction strategies to other biological systems may justify aggressive analytical investigations of unknown features that are likely to be physiologicall y relevant.
Imaging approaches for localizing metabolite s. One of the first steps in the untargeted metabolomic workflow applied to biological tissue is metabolite isolation by sample homogenization. Thus, standard metabolic profiling techniques do not permit high-resolution spatial localization of metabolites within samples. Investigations of heterogeneous tissues such as the brain are therefore complicated by the averaging of various cell types, each with a potentially unique metabolome. Given these limitations, correlating a dysregulated metabolite with a specific region of tissue or cell type can be challenging.
NMR-based imaging technologies have been applied to spatially localize metabolites in intact samples, but these methods have limited chemical specificity and sensitivity [57] [58] [59] . By contrast, mass spectrometrybased approaches relying on matrix-assisted laser desorption ionization (MALDI) offer improved chemical specificity and sensitivity, but they are limited in their application to metabolites owing to background interference caused by the matrix in the low-mass region that is characteristic of metabolites 60 . As an alternative, a matrix-free technique called nanostructure-initiator mass spectrometry (NIMS) has been developed for the analysis of metabolites with high sensitivity and spatial resolution 61, 62 (FIG. 4) .
By using NIMS to analyse 3 μm sections of brain tissue from mice with impaired cholesterol biosynthesis, metabolic precursors of cholesterol were found to localize to the cerebellum and brainstem 2 . These types of NIMS imaging applications coupled with histology will allow metabolite localization patterns to be correlated with tissue pathology and drive developments in our understandin g of chemical physiology.
Untargeted metabolomics applied
Given its sensitivity, high throughput and minimal sample requirements, untargeted metabolomics has wide applicability across a myriad of biological questions. Despite its relatively recent emergence as a global profiling technology, untargeted metabolomics has already increased our understanding of comprehensive cellular metabolism and has been used to address a number of 2 . NIMS is well suited for metabolite imaging because it is highly sensitive and does not suffer from matrix interference in the low-mass range. Sections of frozen tissue are first transferred to a NIMS chip that is subsequently analysed by using a laser-induced desorption and ionization approach. By systematically rastering the laser across the tissue, a mass spectrum is generated from each point. The mass spectral intensity of the metabolite of interest is plotted spatially to generate images, as shown here for cholesterol.
biomedical issues. In particular, it has been useful in identifying altered metabolic pathways in disease that represent novel drug targets: an evolving biomedical application referred to as 'therapeutic metabolomics' (REF. 63 ). An example of this application is the discovery of increased levels of the metabolite 2-hydroxyglutarate in cancer cells with isocitrate dehydrogenase 1 mutations, which are a common feature of a major subset of primary human brain cancers 64 . These results suggest that inhibition of 2-hydroxyglutarate production may be an effective therapeutic approach to slow or halt conversion of a low-grade glioma into lethal secondary glioblastoma. In another example, levels of the sphingolipid dimethylsphingosine were found to be increased in the spinal cords of rats suffering from neuropathic pain 65 . Increased levels of dimethylsphingosine were determined to induce pain-like behaviour in vivo and point to the inhibition of methyltransferase or ceramidase as potential therapeutic approaches for treating chronic pain by blocking dimethylsphingosin e production.
Another area in which untargeted metabolomics has been successfully applied is in characterizing gene and protein function. In addition to successfully identifying the function of unknown genes and proteins, untargeted profiling has been applied to discover new functions for known genes and proteins. By screening for metabolites that accumulate after gene mutation or enzyme inhibition, unanticipated connections between the proteome and metabolome have been established that were not accurately predicted from in vitro activity measurements 66 . For example, to characterize a yeast gene of unknown function (YKL215C), untargeted methods were applied to organisms harbouring a mutation in YKL215C. Increased levels of 5-oxoproline were detected in these organisms, allowing the assignment of YKL215C as an oxoprolinase 48 . In another example, an untargeted screen identified a previously unidentified activity for the yeast enzyme sedoheptulose-1,7-bisphosphatase. The finding that sedoheptulose-1,7-biosphosphatase hydrolyses sedoheptulose-1,7-bisphosphate to sedoheptulose-7-phosphate identified a thermodynamically driven route from trioses produced by glycolysis to the synthesis of ribose 67 . A similar type of enzyme-activity characterization was also accomplished for Mycobacterium tuberculosis by incubating a purified recombinant enzyme with a mycobacterial small molecule extract. The small molecule extract was analysed by LC/MS for altered substrate and product, resulting in the incompletely characterized protein Rv1248c being assigned as a 2-hydroxy-3-oxoadipate synthase 68 . As these examples highlight, untargeted metabolomics has implications not only for therapeutic screening but also for providing chemical insight across a broad area of mechanistic cell biology.
Concluding remarks
Although there has been a long-standing interest in metabolic profiling, only recently have technologies emerged that enable the global analysis of metabolites at a systems level, comparable to its omic predecessors. Unlike genomics, transcriptomics and proteomics, however, metabolomics provides a tool for measuring biochemical activit y directly by monitoring the substrates and products transformed during cellular metabolism. Untargeted profiling of these chemical transformations at a global level serves as a phenotypic readout that can be used effectively in diagnosing pathologies, identifying therapeutic targets of disease and investigating the mechanisms of fundamenta l biological processes.
Although untargeted metabolomics is still in its infancy, early studies have shown that the complexity of cellular metabolism exceeds that expected on the basis of classical biochemical pathways. In this sense, our understanding of metabolism is evolving much like our notion of physic s evolved in the early twentieth century with the emergence of experimental results such as the photoelectric effect, which could not be explained by Newtonian laws 69, 70 . Ultimately, the ideas that emerged from this disparity resulted in a new set of principles for understanding physical phenomena known as quantum mechanics. As meta bolomic technologies continue to advance and facilitate the characterization of unknown pathways, the potential of untargeted metabolomics to shape our understanding of global metabolism is yet to be fully realized.
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Glossary
Imaging mass spectrometry A surface-based approach in which molecules such as metabolites and proteins are spatially analysed in biological specimens. Common imaging mass spectrometry techniques are matrix-assisted laser desorption ionization (MALDI), secondary ion mass spectrometry (SIMS) and nanostructure-initiator mass spectrometry (NIMS).
Ion trap
A type of mass spectrometer that traps ions by using electric or magnetic fields. Once trapped, the ions are analysed to determine their mass-to-charge ratios. Tandem mass spectrometry can also be performed on selected ions by isolating them in the trap and then subjecting them to dissociation.
Matrix-assisted laser desorption ionization (MALDI). A surface-based mass spectrometry approach in which analytes are embedded in a chemical matrix that absorbs energy from an ultraviolet laser, resulting in analyte desorption and ionization.
MS 1 mode
The mode of a mass spectrometer in which only the mass-to-charge ratio of the intact ion is measured. In these experiments no tandem mass spectrometry is performed.
Nanostructure-initiator mass spectrometry (NIMS). A nanostructure surface-based mass spectrometry approach that does not require a matrix. NIMS is commonly used for metabolomic studies and metabolite imaging.
Nuclear magnetic resonance (NMR). An analytical technique that exploits the different responses to radiofrequency stimuli by chemically distinct atomic nuclei in an external magnetic field to provide information about the structure and dynamics of molecules.
Quadrupole time-of-flight (QTOF). A mass spectrometer commonly used to perform untargeted metabolomics. By using the quadrupole as a focusing lens, the time-of-flight mass analyser can be used to acquire profiling data. Alternatively, the quadrupole can be used to select ions for tandem mass spectrometry experiments.
Tandem mass spectrometry
(MS/MS). A type of mass spectrometry in which ions are selectively isolated and then fragmented. The mass-to-charge ratio of each molecular fragment is measured and used for structural characterization.
Triple quadrupole (QqQ) . A type of mass spectrometer that is often used for targeted studies owing to its sensitivity and specificity. The QqQ analyser consists of a quadrupole, a quadrupole collision cell and a second quadrupole, respectively. The first selects and analyses ions of interest, the second is used as a collision cell for fragmentation and the third analyses fragments.
